loading
전일 마감가:
$1.56
열려 있는:
$1.61
하루 거래량:
17,670
Relative Volume:
0.14
시가총액:
$4.15M
수익:
$1.31M
순이익/손실:
$-7.56M
주가수익비율:
-0.1516
EPS:
-10.2926
순현금흐름:
$-8.25M
1주 성능:
-8.77%
1개월 성능:
+13.04%
6개월 성능:
-25.91%
1년 성능:
-85.06%
1일 변동 폭
Value
$1.492
$1.61
1주일 범위
Value
$1.46
$1.78
52주 변동 폭
Value
$1.22
$10.56

60 Degrees Pharmaceuticals Inc Stock (SXTP) Company Profile

Name
명칭
60 Degrees Pharmaceuticals Inc
Name
전화
202-327-5422
Name
주소
1025 CONNECTICUT AVENUE NW, WASHINGTON
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2026-08-12
Name
최신 SEC 제출 서류
Name
SXTP's Discussions on Twitter

Compare SXTP vs VRTX, REGN, ARGX, ALNY, RVMD

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
SXTP icon
SXTP
60 Degrees Pharmaceuticals Inc
1.56 4.15M 1.31M -7.56M -8.25M -10.29
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
485.39 123.19B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
664.52 69.67B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
877.62 54.58B 4.16B 1.29B 734.26M 19.58
ALNY icon
ALNY
Alnylam Pharmaceuticals Inc
298.76 39.89B 4.29B 577.22M 641.34M 4.2086
RVMD icon
RVMD
Revolution Medicines Inc
186.88 39.73B 742.00K -1.37B -1.07B -7.0731

60 Degrees Pharmaceuticals Inc 주식(SXTP)의 최신 뉴스

pulisher
Jul 11, 2026

Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 11, 2026
pulisher
Jul 10, 2026

60 Degrees Pharmaceuticals, Inc. Warranton 60 Degrees Ph Financial Disclosures & SEC Filings - TradingView

Jul 10, 2026
pulisher
Jul 10, 2026

Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 10, 2026
pulisher
Jul 09, 2026

60 Degrees Pharmaceuticals (NASDAQ: SXTP) Files 8-K Report Detailing Company Updates and Security Information - Minichart

Jul 09, 2026
pulisher
Jul 09, 2026

Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 09, 2026
pulisher
Jul 09, 2026

Interim Trial Plan Finalized for Tafenoquine Babesiosis Study - TipRanks

Jul 09, 2026
pulisher
Jul 09, 2026

60 Degrees Pharmaceuticals readies interim analysis plan for tafenoquine babesiosis trial - TradingView

Jul 09, 2026
pulisher
Jul 09, 2026

60 Degrees Pharmaceuticals (SXTP) sets tafenoquine babesiosis interim analysis and sNDA path - Stock Titan

Jul 09, 2026
pulisher
Jul 09, 2026

Price to earnings forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jul 09, 2026
pulisher
Jul 08, 2026

60 Degrees Pharmaceuticals to Advance Castanospermine for Tick-Borne Diseases Through Florida State University Deal - Moomoo

Jul 08, 2026
pulisher
Jul 08, 2026

60 Degrees Pharmaceuticals Announces Exclusive Option Agreement with Florida State University to Advance Castanospermine for Tick-Borne Diseases - Yahoo Finance

Jul 08, 2026
pulisher
Jul 07, 2026

Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 07, 2026
pulisher
Jul 06, 2026

Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTP - TradingView

Jul 06, 2026
pulisher
Jul 03, 2026

SXTP | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative

Jul 03, 2026
pulisher
Jul 03, 2026

SXTPW | 60 Degrees Pharmaceuticals, Inc. Executive Compensation - Quiver Quantitative

Jul 03, 2026
pulisher
Jul 02, 2026

Equity plan hike and reverse split up for 60 Degrees (SXTP) shareholder vote - Stock Titan

Jul 02, 2026
pulisher
Jul 01, 2026

60 Degrees Pharma babesiosis study clears safety review - Investing.com UK

Jul 01, 2026
pulisher
Jul 01, 2026

60 Degrees Pharma babesiosis study clears safety review By Investing.com - Investing.com Nigeria

Jul 01, 2026
pulisher
Jul 01, 2026

60 Degrees Pharmaceuticals Announces Positive Recommendation from Data Safety Monitoring Board for B-FREE Phase 2 Study of Tafenoquine for Treatment of Chronic Babesiosis Patients with Severe Fatigue - Yahoo Finance Singapore

Jul 01, 2026
pulisher
Jul 01, 2026

Safety board backs 60 Degrees Pharma's babesiosis trial continuation - Stock Titan

Jul 01, 2026
pulisher
Jun 28, 2026

SXTP Financials: Revenue Breakdown, Margins & Competitor Comparison - Intellectia AI

Jun 28, 2026
pulisher
Jun 27, 2026

SXTP Forecast — Price Target — Prediction for 2027 - TradingView

Jun 27, 2026
pulisher
Jun 26, 2026

60 Degrees Pharmaceuticals, Inc. Actuals & Estimates (BOATS:SXTP) - TradingView

Jun 26, 2026
pulisher
Jun 26, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 26, 2026
pulisher
Jun 25, 2026

Price to book forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 25, 2026
pulisher
Jun 25, 2026

Price to sales forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 25, 2026
pulisher
Jun 24, 2026

Enterprise value to EBITDA forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Enterprise value to EBIT forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 24, 2026
pulisher
Jun 24, 2026

Enterprise value to revenue forward of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 24, 2026
pulisher
Jun 23, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 23, 2026
pulisher
Jun 22, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 22, 2026
pulisher
Jun 21, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 21, 2026
pulisher
Jun 19, 2026

Number of shareholders of 60 Degrees Pharmaceuticals, Inc. – NASDAQ:SXTPW - TradingView

Jun 19, 2026
pulisher
Jun 18, 2026

SXTP News | 60 DEGREES PHARMA INC (NASDAQ:SXTP) - ChartMill

Jun 18, 2026
pulisher
Jun 18, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Institutional Confidence - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 18, 2026
pulisher
Jun 18, 2026

60 Degrees Pharmaceuticals Inc - TradingKey

Jun 18, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTP) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Institutional Confidence - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jun 17, 2026
pulisher
Jun 17, 2026

60 Degrees Pharmaceuticals Inc (SXTPW) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Jun 17, 2026
pulisher
Jun 15, 2026

Top Executive Makes Bold Move With Fresh Buy in Pharma Stock - TipRanks

Jun 15, 2026
pulisher
Jun 15, 2026

Insider Buying: Geoffrey Dow Acquires Additional Shares of 60 De - GuruFocus

Jun 15, 2026
pulisher
Jun 15, 2026

60 degrees pharmaceuticals CEO buys $10,131 in stock By Investing.com - Investing.com South Africa

Jun 15, 2026
pulisher
Jun 15, 2026

60 degrees pharmaceuticals CEO buys $10,131 in stock - Investing.com

Jun 15, 2026

60 Degrees Pharmaceuticals Inc (SXTP) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading

60 Degrees Pharmaceuticals Inc 주식 (SXTP) 내부자 거래

내부자 거래 관계 날짜 거래 비용 #주식 가치 ($) #주식 총계
DOW GEOFFREY S
President and CEO
Dec 15 '25
Buy
0.80
9,670
7,759
59,618
DOW GEOFFREY S
President and CEO
Dec 10 '25
Buy
0.95
9,350
8,886
46,335
DOW GEOFFREY S
President and CEO
Dec 11 '25
Buy
0.92
3,613
3,318
49,948
$56.43
price down icon 2.64%
$115.61
price down icon 2.24%
$35.97
price down icon 2.28%
$68.27
price down icon 10.83%
ONC ONC
$298.70
price down icon 1.36%
$186.88
price down icon 2.22%
자본화:     |  볼륨(24시간):